- Clinical studies in viral hepatitis and liver cancer, including epidemiology, clinical trials and prognosis
- Healthcare delivery for patients with viral hepatitis and liver cancer
Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.
J Hepatol. 2019 Jan 04;:
Gastroenterology. 2018 Mar 27;:
Semin Liver Dis. 2017 Nov;37(4):287-295
Hepatology. 2017 Oct 23;:
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients With Unresectable Hepatocellular Carcinoma Lesions.
Clin Cancer Res. 2017 Oct 10;:
Toronto HCC Risk Index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
J Hepatol. 2017 Aug 24;:
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
Ann Hepatol. 2017 Sep-Oct;16(5):765-771
Ann Hepatol. 2017 Aug 01;16(4):478-479
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
J Hepatol. 2016 Nov 3;:
Hepatology. 2016 Sep 12;
Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI)